HT
FLNA

HAP Trading’s Filana Therapeutics FLNA Stock Holding History

HAP Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,100
Closed -$999K – 872
2024
Q4 		$999K Buy
100,100
+8,500
+9% +$149K 0.09% 130
2024
Q3 		$488K Buy
91,600
+1,600
+2% +$36.8K 0.06% 197
2024
Q2 		$545K Hold
90,000
– – 0.06% 180
2024
Q1 		$266K Buy
+90,000
New +$2.07M 0.03% 261
2023
Q1 		– Sell
-20,100
Closed -$181K – 1606
2022
Q4 		$181K Buy
20,100
+8,400
+72% +$302K 0.02% 491
2022
Q3 		$73K Sell
11,700
-3,700
-24% -$99.9K ﹤0.01% 879
2022
Q2 		$159K Buy
15,400
+3,400
+28% +$85.9K 0.01% 781
2022
Q1 		$119K Sell
12,000
-3,300
-22% -$140K 0.01% 991
2021
Q4 		$138K Sell
15,300
-10,600
-41% -$556K ﹤0.01% 1130
2021
Q3 		$167K Buy
25,900
+13,400
+107% +$1.12M 0.01% 1099
2021
Q2 		$63K Sell
12,500
-6,000
-32% -$321K ﹤0.01% 1392
2021
Q1 		$93K Buy
+18,500
New +$728K 0.01% 977

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

HAP Trading's FLNA Position: Q4 2021 in Review

HAP Trading sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 13,848 shares — an estimated $726K sold.

HAP Trading first reported a position in FLNA in Q2 2021 and held it in 2 quarters. The position peaked at $891K in Q2 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

  • HAP Trading reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 13,848 Filana Therapeutics shares in Q4 2021, an estimated $726K.
  • HAP Trading first reported a position in Filana Therapeutics in Q2 2021 and held it in 2 quarters.
  • HAP Trading's Filana Therapeutics position peaked at $891K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.